Tree shrew depression model construction method
通过在树鼩抑郁症模型中同时给予利血平和去甲肾上腺素,解决了现有模型中动物死亡率高的问题,实现了更安全和有效的抑郁症模型构建,提供了一个具有可靠性和 Animal model of effectiveness.
Patent Information
- Application Number
- CN202411564220.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-11-05
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing animal model construction methods for depression are difficult to effectively reduce animal mortality and are difficult to simulate the complex pathological mechanism of human depression.
By giving reserpine and norepinephrine to the tree shrews intraperitoneal injection, the inhibitory effect of reserpine vesicle reuptake and combined with the dilution injection scheme of norepinephrine, it lasted for 14 days, reducing the depression model of the tree shrews mortality rate.
The mortality rate of tree shrew depression model was significantly reduced while maintaining the effectiveness of the model, and the appearance of depression symptoms was verified through behavioral testing and biomarker analysis, providing a more reliable animal model.
Smart Images

Figure CN119074733A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of disease animal model construction, and in particular relates to a method for constructing a tree shrew depression model. Background Art
[0002] Depression is a type of affective disorder characterized by high prevalence, high recurrence rate, high suicide rate and high disability rate. Whether from the perspective of clinical phenomenology, pathological mechanism or disease treatment, depression is an extremely complex mental illness. The World Health Organization lists depression as the fourth leading cause of disability in the world, and predicts that by 2030, depression will be the leading cause of death worldwide. The establishment of an animal model of depression can help researchers explore the pathogenesis of depression and study antidepressant drugs, so creating an ideal animal model is one of the technical difficulties in overcoming depression research. Evolutionary research evidence shows that tree shrews are a small animal closely related to primates, with a high brain-to-body mass ratio, a relatively developed nervous system and a stress system similar to that of humans, so they have irreplaceable advantages over other non-primate animal models. Summary of the invention
[0003] The purpose of the present invention is to provide a method for constructing a tree shrew depression model.
[0004] The object of the present invention is achieved as follows: (1) 10 mg of reserpine is dissolved in 10 μl of glacial acetic acid, and sterile distilled water is added to make the volume to 10 ml to prepare a 1 mg / ml stock solution, and norepinephrine is prepared into a 1 mg / ml stock solution with 5% glucose injection; (2) the reserpine stock solution in step (1) is diluted 10 times with sterile distilled water and then injected intraperitoneally into tree shrews; 2 hours later, the norepinephrine stock solution in step (1) is diluted 50 times with sterile distilled water and then injected intraperitoneally into tree shrews, and the dilution is continued for 14 days.
[0005] Reserpine is a vesicle reuptake inhibitor, which can inhibit the reuptake of monoamine neurotransmitters (NA, Ad, DA and 5-HT) by vesicles and keep them outside the vesicles, which are degraded by monoamine oxidase, thereby gradually reducing the neurotransmitters in the vesicles and even exhausting them (reserpine mainly acts on vesicle monoamine transporter 2 (vMAT2)). Animals may experience ptosis, hypothermia and rigidity. However, the depression model induced by reserpine is prone to cause animal death. Therefore, the present invention proposes to give norepinephrine at the same time as reserpine. Norepinephrine cannot pass through the blood-brain barrier and will not affect the effect of reserpine on the brain. Experiments have shown that when both are given to tree shrews by intraperitoneal injection at the same time, the mortality rate of the tree shrew depression model is greatly reduced. BRIEF DESCRIPTION OF THE DRAWINGS
[0006] Figure 1This is a comparison table of animal mortality rates among the control group, reserpine group, and reserpine + norepinephrine group; Figure 2 This is a comparison table of the spontaneous activity scores of the control group, reserpine group, and reserpine + norepinephrine group; Figure 3 This is a comparison table of the sugar water preference experiment among the control group, reserpine group, and reserpine + norepinephrine group; Figure 4 This is a comparison table of 5-HT content in the control group, reserpine group, and reserpine + norepinephrine group; Figure 5 This is a comparison table of norepinephrine content in the control group, reserpine group, and reserpine + norepinephrine group; Figure 6 This is a comparison table of dopamine content in the control group, reserpine group, and reserpine + norepinephrine group. DETAILED DESCRIPTION
[0007] The technical solution of the present invention will be described clearly and completely in combination with the embodiments below. Obviously, the described embodiments are only part of the embodiments of the present invention, but not all of them. All other embodiments belong to the protection scope of the present invention.
[0008] A method for constructing a tree shrew depression model comprises the following steps: (1) dissolving 10 mg of reserpine in 10 μl of glacial acetic acid, adding sterile distilled water to make the volume to 10 ml, and preparing a 1 mg / ml stock solution; and preparing norepinephrine with 5% glucose injection to make a 1 mg / ml stock solution; (2) diluting the reserpine stock solution in step (1) by 10 times with sterile distilled water and injecting it into the tree shrew intraperitoneally; 2 hours later, diluting the norepinephrine stock solution in step (1) by 50 times with sterile distilled water and injecting it into the tree shrew intraperitoneally, and continuing for 14 days.
[0009] The tree shrew is a CL-level Chinese-Burmese tree shrew.
[0010] The tree shrew has a body mass of 120-150 g.
[0011] The tree shrews are kept at room temperature of 24±2°C, relative humidity of 50±5%, and a light / dark cycle of 12h / 12h.
[0012] Twelve CL-grade Chinese-Burmese tree shrews, weighing 120-150 g, were purchased from the Institute of Medical Biology, Chinese Academy of Medical Sciences [SCXK (Yunnan) K2023-0003] and kept in the ordinary animal room of Yunnan Luoyu Biotechnology Co., Ltd. [SYXK (Yunnan) K2021-0003] in stainless steel cages at room temperature (24±2)℃, relative humidity (50±5)%, and light / dark cycle of 12h / 12h.
[0013] Multifunctional microplate reader (Feyond-A3000).
[0014] Reserpine (Sigma 83580): Dissolve 10 mg of reserpine in 10 μl of glacial acetic acid, add sterile distilled water to make up to 10 ml, prepare a 1 mg / ml stock solution, and dilute it 10 times with sterile distilled water to a working concentration of 100 μg / ml for intraperitoneal injection.
[0015] Norepinephrine (Solebo SN8550): 10 mg of norepinephrine is dissolved in 10 ml of 5% glucose injection to make a 1 mg / ml stock solution. When injected intraperitoneally, it is diluted 50 times with sterile distilled water to a working concentration of 20 μg / ml.
[0016] The 5-hydroxytryptamine (ST / 5-HT) Elisa kit, the norepinephrine (NA / NE) Elisa kit, and the dopamine (DA) Elisa kit were purchased from Wuhan Elisa.
[0017] Twelve tree shrews were randomly divided into three groups: control group, reserpine group, and reserpine + norepinephrine group. Reserpine group: intraperitoneal injection of 0.6 mg / kg daily for 14 days; Reserpine + norepinephrine group: 0.6 mg / kg of reserpine was intraperitoneally injected daily, followed by 0.05 mg / kg of norepinephrine intraperitoneally injected 2 hours later, for 14 days; Control group: intraperitoneal injection of an equal amount of normal saline for 14 days; After the modeling was completed, behavioral tests were performed. After the test was completed, the animals were anesthetized, blood was collected from the abdominal aorta, and the brain hippocampus, amygdala, prefrontal cortex, thalamus and other tissues were separated on a freezing table and stored in liquid nitrogen for later use.
[0018] After the modeling was completed, the autonomous activity of the tree shrews was analyzed for 5 minutes. The autonomous activity score included movement (horizontal displacement) and jumping (vertical displacement). The sum of the two times represented the relative activity of the tree shrews in each group.
[0019] Sucrose preference experiments are often used to assess the anhedonia of tree shrews. The reduction in the sucrose consumption ratio of tree shrews indicates the occurrence of depression-like behaviors with obvious anhedonia. The first is the adaptation phase. Each tree shrew is given two bottles of 1% sucrose water at the same time for 24 hours. Then each tree shrew is given one bottle of sucrose water and one bottle of pure water for 24 hours. During this period, the position of the water bottle is changed every 2 hours to prevent the tree shrew from having spatial memory of the position and thus affecting the experimental results. Then comes the formal experiment. Before the experiment, the tree shrews are fasted and deprived of water for 12 hours. Each tree shrew is given one bottle of 1% sucrose water and one bottle of pure water. The volume of water in the horizontal plane is recorded in advance. After 6 hours (9:00-15:00), the volume of the remaining sugar water and pure water is measured and recorded with a measuring cylinder. The percentage of sugar water preference is calculated according to the formula: Sugar water preference percentage = 1% sucrose drinking amount / (1% sucrose drinking amount + pure water drinking amount) × 100%.
[0020] The operation process is strictly carried out according to the instructions. The specific steps are as follows: (1) Set up standard wells, blank wells, and sample wells respectively. Add 50 μL of the diluted standard to the standard wells, 50 μL of the sample diluent to the blank wells, and 50 μL of the sample to be tested to the remaining wells. Immediately add 50 μL of the prepared biotinylated antibody working solution to each well. Coat the ELISA plate and incubate at 37°C for 45 minutes. (2) Shake off all the liquid in the wells and pat dry on clean absorbent paper. Add 350 μL of washing solution to each well, soak for 1 minute, absorb or shake off the liquid in the ELISA plate, and pat dry. Repeat this washing step 3 times; (3) Add 100 μL of HRP conjugate working solution to each well, cover the plate with film, and incubate at 37°C for 30 minutes; (4) Shake off the liquid in the wells and wash the plate 5 times using the same method as step 2; (5) Add 90 μL of substrate solution (TMB) to each well, cover the ELISA plate with a film, and incubate at 37°C in the dark for about 15 minutes; (6) Add 50 μL of stop solution to each well to terminate the reaction; (7) Immediately measure the optical density (OD value) of each well using a microplate reader at a wavelength of 450 nm.
Claims
1. A method for constructing a tree shrew depression model, characterized in that: The steps include: (1) Dissolve 10 mg of reserpine in 10 μl of glacial acetic acid, add sterile distilled water to make up to 10 ml, and prepare a 1 mg / ml stock solution. Use 5% glucose injection to prepare a 1 mg / ml stock solution of norepinephrine. (2) Dilute the reserpine stock solution in step (1) 10 times with sterile distilled water and inject it intraperitoneally into the tree shrew. After 2 hours, dilute the norepinephrine stock solution in step (1) 50 times with sterile distilled water and inject it intraperitoneally into the tree shrew. Continue for 14 days.
2. The method for constructing a tree shrew depression model according to claim 1, characterized in that: The tree shrew is a CL-level Chinese-Burmese tree shrew.
3. The method for constructing a tree shrew depression model according to claim 1, characterized in that: The tree shrew has a body mass of 120-150 g.
4. The method for constructing a tree shrew depression model according to claim 1, characterized in that: The tree shrews are kept at room temperature of 24±2°C, relative humidity of 50±5%, and a light / dark cycle of 12h / 12h.
Citation Information
Patent Citations
Chronic depression animal model, drug screening method and application
CN116270643A
Monoamine reuptake inhibitor given by mixing lycium chinense thereinto
JP2005035999A
Cited By
Preparation method of tree shrew depression model
CN120266809A
